MSCI's post-earnings rally leaves shorts stranded at a year-high

MSCI is the most shorted name among its closest financial data peers right now, with short interest at 2.59% of the free float and the cost to borrow tripling in a single week, even as the stock itself jumped 5.5% after reporting Q3 results on October 20.

Among peers, the picture looks less crowded. SPGI gained 6.9% on the week and FDS gained 7.4%, both without the same short-rebuilding dynamic visible in MSCI's lending data. MCO rose a more modest 2.4%. MSCI's short interest, at its highest level in at least a year, is not matched by elevated short positioning across the group. That contrast matters: bears singled out MSCI specifically into its print, and they have not covered since.

The positioning picture is a study in divergence between cost and conviction. Short interest held essentially flat in the days immediately around earnings, adding just 0.3% on October 20 and 1.1% over the week. The one-month gain of 59% in shares short remains the dominant fact, and it predates the print. What changed after the results dropped was the cost to borrow. It jumped from 0.22% in mid-October to 0.74% on October 20, a 232% move in a week. That is not a squeeze, availability remains effectively unconstrained with 72 million shares available against fewer than 2 million shorted. It is a pricing signal: demand for new borrows rose sharply around the print, and lenders adjusted rates to match. Options, by contrast, are calm. The put/call ratio eased to 1.15 on October 20, just below its 20-day average of 1.17, and the z-score is negligible at -0.05. No unusual defensive positioning is visible in derivatives.

The Street moved decisively in the other direction. Five analyst firms updated targets on October 21 alone, all maintaining positive ratings, and four of the five raised their price targets. JP Morgan lifted its target to $710 from $685, Wells Fargo moved to $720 from $685, and Morgan Stanley nudged higher to $671 from $662. Evercore raised to $726. The mean consensus target across the group now stands at $678, implying roughly 15% upside from the October 20 close of $591.69. That followed a brief round of cuts in mid-October, when JP Morgan and Morgan Stanley both trimmed to the high $600s ahead of the print; those cuts have now been fully reversed and then some. The factor picture is less uniformly positive. MSCI ranks in the 97th percentile on dividend score and 68th on days-to-cover, but EPS momentum over 30 and 90 days sits in the 36th to 42nd percentile range, and the EV/EBIT factor scores in the 19th percentile, reflecting a valuation premium the market is clearly still willing to pay for quality.

One ownership detail worth noting: director Rajat Taneja made an open-market purchase of 1,786 shares at $560 in early September, spending just over $1 million with no pre-arranged trading plan attached. That is a straightforward discretionary buy from a board member, filed cleanly under SEC Form 4. The CFO's sale of 450 shares in October was conducted under a 10b5-1 plan, the standard scheduled-disposal mechanism, and carries far less signal. On the institutional side, T. Rowe Price added 604,800 shares in the quarter to September 30, making it one of the larger incremental buyers among top holders, while Baron Capital added 512,364 shares as of June 30. Neither Vanguard entity on the 13D/G register holds an activist posture; all filings are passive Schedule 13G disclosures.

Q3 earnings printed on October 20, and the last comparable result with a recorded price reaction was Q2 in July, when the stock fell 8.7% on the day and 7.3% over the following five days. That makes the 5% post-print gain this week a meaningful reversal of that pattern. The next scheduled event is Q4 earnings on January 26, 2027, giving the market 97 days to reassess whether the short rebuilding that accumulated over the past month starts to unwind, or whether the bears who absorbed a 5.5% move against them find reason to add further at the elevated borrow cost now on offer.